Cetera Investment Advisers
ATOS icon

Cetera Investment Advisers’s Atossa Therapeutics ATOS Stock Holding History

Cetera Investment Advisers’s Portfolio ATOS Stock Details ATOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2,282
Closed -$32.3K – 3983
2024
Q4 		$32.3K Sell
2,282
-794
-26% -$15.5K ﹤0.01% 3685
2024
Q3 		$70.1K Sell
3,076
-894
-23% -$18K ﹤0.01% 3576
2024
Q2 		$70.9K Buy
3,970
+855
+27% +$18.9K ﹤0.01% 3564
2024
Q1 		$84.1K Buy
+3,115
New +$50K ﹤0.01% 3523

Other funds holding ATOS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Cetera Investment Advisers's ATOS Position: Q1 2025 in Review

Cetera Investment Advisers sold out of Atossa Therapeutics (ATOS) in Q1 2025, closing a stake of 2,282 shares — an estimated $32.3K sold.

Cetera Investment Advisers first reported a position in ATOS in Q1 2024 and held it in 4 quarters. The position peaked at $84.1K in Q1 2024. 83 funds tracked by Wall St. Rank hold ATOS as of Q1 2025.

  • Cetera Investment Advisers reported no remaining Atossa Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Cetera Investment Advisers sold 2,282 Atossa Therapeutics shares in Q1 2025, an estimated $32.3K.
  • Cetera Investment Advisers first reported a position in Atossa Therapeutics in Q1 2024 and held it in 4 quarters.
  • Cetera Investment Advisers's Atossa Therapeutics position peaked at $84.1K in Q1 2024.
  • 83 funds tracked by Wall St. Rank held Atossa Therapeutics as of Q1 2025.

Based on Cetera Investment Advisers's 13F filing for Q1 2025, filed 6 May 2025.